EI
IPXL

EAM Investors’s Impax Laboratories, Inc. IPXL Stock Holding History

EAM Investors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-69,111
Closed -$3.24M – 416
2015
Q1 		$3.24M Sell
69,111
-7,970
-10% -$317K 0.37% 129
2014
Q4 		$2.44M Buy
+77,081
New +$2.26M 0.34% 131

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

EAM Investors's IPXL Position: Q2 2015 in Review

EAM Investors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2015, closing a stake of 69,111 shares — an estimated $3.24M sold.

EAM Investors first reported a position in IPXL in Q4 2014 and held it in 2 quarters. The position peaked at $3.24M in Q1 2015. 197 funds tracked by Wall St. Rank hold IPXL as of Q2 2015.

  • EAM Investors reported no remaining Impax Laboratories, Inc. position as of Q2 2015 after selling out during the quarter.
  • EAM Investors sold 69,111 Impax Laboratories, Inc. shares in Q2 2015, an estimated $3.24M.
  • EAM Investors first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 2 quarters.
  • EAM Investors's Impax Laboratories, Inc. position peaked at $3.24M in Q1 2015.
  • 197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2015.

Based on EAM Investors's 13F filing for Q2 2015, filed 13 Aug 2015.